Business
Stock Of MoonLake Immunotherapeutics (NASDAQ: MLTX) Dropped By -17.31 Percent Over The Past Month, Is There Room For Downside?
MoonLake Immunotherapeutics (NASDAQ:MLTX)’s traded shares stood at 0.81 million during the last session, with the company’s beta value hitting 1.32. At the close of trading,
